Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BX004-A in Cystic Fibrosis with Chronic PsA Infection
NCT05010577Phase 2Completed
- Sponsor
- BiomX
- Start
- Jun 2022
- Primary completion
- Mar 2024
- Modality
- Single Strain Products, Multi-strain Products
- Countries
- 5
01
Overview
A Phase 2 trial of BX004 in chronic Pseudomonas aeruginosa infection, sponsored by BiomX. Started Jun 2022; status: completed.
02
Drugs
BX004
03
Conditions
chronic Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT05010577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05010577.